Literature DB >> 24146067

Biphasic activation of nuclear factor kappa B and expression of p65 and c-Rel after traumatic brain injury in rats.

Yang-Chun Hu1, Qing Sun, Wei Li, Ding-Ding Zhang, Biao Ma, Song Li, Wei-De Li, Meng-Liang Zhou, Chun-Hua Hang.   

Abstract

BACKGROUND AND OBJECT: Nuclear factor kappa B (NF-κB) functions as a key regulator in the central nervous system and regulates the inflammatory pathway. There are two peaks of cerebral NF-κB activation after neonatal hypoxia-ischemia and subarachnoid hemorrhage. Our previous studies found that NF-κB activity was up-regulated at an early stage and remained elevated at day 7 after traumatic brain injury (TBI). However, data are lacking regarding an overview of NF-κB activity and expression of NF-κB subunits after TBI. Hence, the current study was designed to detect the time course of NF-κB activation and expression of NF-κB p65 and c-Rel subunits around the contused cortex following TBI.
METHODS: Adult Sprague-Dawley rats were randomly divided into sham and TBI groups at different time points. A TBI model was induced, and then the NF-κB DNA-binding activity in the surrounding areas of injured brain was detected by electrophoretic mobility shift assay. Western blotting was used to measure the protein levels of p65 and c-Rel in the nucleus. The concentrations of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were detected by enzyme-linked immunosorbent assay. Moreover, the distribution of c-Rel and p65 was examined by immunohistochemical studies.
RESULTS: There were double peaks of cerebral cortical NF-κB activity, at 3 and 10 days post-injury. Additionally, protein levels of p65 were found to be elevated and peaked at 3 days after TBI, while levels of c-Rel were elevated significantly during the later phase of injury. Furthermore, TNF-α and IL-1β concentrations also showed a biphasic increase.
CONCLUSIONS: Biphasic activation of NF-κB could be induced after experimental TBI in rats. NF-κB p65 and c-Rel subunits were elevated at different post-TBI time periods, leading to a hypothesis that different NF-κB subunits might be involved in different pathophysiological processes after TBI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24146067     DOI: 10.1007/s00011-013-0677-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  33 in total

Review 1.  Roles for NF-kappaB in nerve cell survival, plasticity, and disease.

Authors:  M P Mattson; M K Meffert
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

2.  Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum.

Authors:  Z H Qin; Y Wang; M Nakai; T N Chase
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

3.  Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta.

Authors:  Marina Pizzi; Francesca Goffi; Flora Boroni; Marina Benarese; Scott E Perkins; Hsiou-Chi Liou; PierFranco Spano
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

4.  Inducible degradation of I kappa B alpha in vitro and in vivo requires the acidic C-terminal domain of the protein.

Authors:  M S Rodriguez; I Michalopoulos; F Arenzana-Seisdedos; R T Hay
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

5.  High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells.

Authors:  F Lezoualc'h; Y Sagara; F Holsboer; C Behl
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

6.  The ability of CD40L, but not lipopolysaccharide, to initiate immunoglobulin switching to immunoglobulin G1 is explained by differential induction of NF-kappaB/Rel proteins.

Authors:  S C Lin; H H Wortis; J Stavnezer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats.

Authors:  Chun-hua Hang; Ji-xin Shi; Jie Tian; Jie-shou Li; Wei Wu; Hong-xia Yin
Journal:  Brain Res       Date:  2004-11-05       Impact factor: 3.252

8.  Nuclear factor-kappa B in rat brain: enhanced DNA-binding activity following convulsant-induced seizures.

Authors:  A V Prasad; W H Pilcher; S A Joseph
Journal:  Neurosci Lett       Date:  1994-03-28       Impact factor: 3.046

9.  Constitutive nuclear factor-kappa B activity is required for central neuron survival.

Authors:  Asha L Bhakar; Laura-Lee Tannis; Christine Zeindler; Maria Pia Russo; Christian Jobin; David S Park; Sandra MacPherson; Philip A Barker
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

10.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

View more
  14 in total

1.  Impacts of stellate ganglion block on plasma NF-κB and inflammatory factors of TBI patients.

Authors:  Xi Yang; Zhong Shi; Xia Li; Jun Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  K(+) channel blocker-induced neuroinflammatory response and neurological disorders: immunomodulatory effects of astaxanthin.

Authors:  Nesrine Sifi; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Inflamm Res       Date:  2016-04-06       Impact factor: 4.575

3.  Neuroprotective Effects of Resatorvid Against Traumatic Brain Injury in Rat: Involvement of Neuronal Autophagy and TLR4 Signaling Pathway.

Authors:  Yan Feng; Junling Gao; Ying Cui; Minghang Li; Ran Li; Changmeng Cui; Jianzhong Cui
Journal:  Cell Mol Neurobiol       Date:  2016-03-10       Impact factor: 5.046

4.  Inhibition of Inducible Nitric Oxide Synthase Attenuates Deficits in Synaptic Plasticity and Brain Functions Following Traumatic Brain Injury.

Authors:  Bo Wang; Shuangshuang Han
Journal:  Cerebellum       Date:  2018-08       Impact factor: 3.847

5.  Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury.

Authors:  Aric F Logsdon; Brandon P Lucke-Wold; Linda Nguyen; Rae R Matsumoto; Ryan C Turner; Charles L Rosen; Jason D Huber
Journal:  Brain Res       Date:  2016-04-27       Impact factor: 3.252

6.  The Effect of Rutin on Experimental Traumatic Brain Injury and Edema in Rats.

Authors:  Sahin Yuceli; Gulce Naz Yazici; Renad Mammadov; Halis Suleyman; Mustafa Kaya; Selcuk Ozdogan
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

7.  Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro.

Authors:  Qing Sun; Wei Wu; Yang-Chun Hu; Hua Li; Dingding Zhang; Song Li; Wei Li; Wei-De Li; Biao Ma; Jian-Hong Zhu; Meng-Liang Zhou; Chun-Hua Hang
Journal:  J Neuroinflammation       Date:  2014-06-12       Impact factor: 8.322

8.  Biphasic activation of nuclear factor-κB and expression of p65 and c-Rel following traumatic neuronal injury.

Authors:  Huasheng Zhang; Dingding Zhang; Hua Li; Huiying Yan; Zihuan Zhang; Chenhui Zhou; Qiang Chen; Zhennan Ye; Chunhua Hang
Journal:  Int J Mol Med       Date:  2018-03-14       Impact factor: 4.101

9.  Real-Time Noninvasive Bioluminescence, Ultrasound and Photoacoustic Imaging in NFκB-RE-Luc Transgenic Mice Reveal Glia Maturation Factor-Mediated Immediate and Sustained Spatio-Temporal Activation of NFκB Signaling Post-Traumatic Brain Injury in a Gender-Specific Manner.

Authors:  Sudhanshu P Raikwar; Ramasamy Thangavel; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Duraisamy Kempuraj; Kristopher Wu; Osaid Khan; Kieran Bazley; Bret Bussinger; Klaudia Kukulka; Smita Zaheer; Shankar S Iyer; Raghav Govindarajan; Casey Burton; Donald James; Asgar Zaheer
Journal:  Cell Mol Neurobiol       Date:  2020-08-12       Impact factor: 5.046

10.  Age and Diet Affect Genetically Separable Secondary Injuries that Cause Acute Mortality Following Traumatic Brain Injury in Drosophila.

Authors:  Rebeccah J Katzenberger; Barry Ganetzky; David A Wassarman
Journal:  G3 (Bethesda)       Date:  2016-12-07       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.